Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33444100555;100556;100557 chr2:178536417;178536416;178536415chr2:179401144;179401143;179401142
N2AB3180395632;95633;95634 chr2:178536417;178536416;178536415chr2:179401144;179401143;179401142
N2A3087692851;92852;92853 chr2:178536417;178536416;178536415chr2:179401144;179401143;179401142
N2B2437973360;73361;73362 chr2:178536417;178536416;178536415chr2:179401144;179401143;179401142
Novex-12450473735;73736;73737 chr2:178536417;178536416;178536415chr2:179401144;179401143;179401142
Novex-22457173936;73937;73938 chr2:178536417;178536416;178536415chr2:179401144;179401143;179401142
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Fn3-131
  • Domain position: 53
  • Structural Position: 70
  • Q(SASA): 0.494
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I None None 0.999 N 0.808 0.413 0.385906861911 gnomAD-4.0.0 6.84354E-07 None None None None I None 0 2.23724E-05 None 0 0 None 0 0 0 0 0
T/K None None 0.999 N 0.767 0.498 0.374076547971 gnomAD-4.0.0 2.05306E-06 None None None None I None 0 0 None 0 0 None 0 0 2.6987E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.0921 likely_benign 0.0905 benign -0.234 Destabilizing 0.981 D 0.502 neutral N 0.489118687 None None I
T/C 0.583 likely_pathogenic 0.5555 ambiguous -0.455 Destabilizing 1.0 D 0.783 deleterious None None None None I
T/D 0.3715 ambiguous 0.3588 ambiguous -0.172 Destabilizing 0.999 D 0.767 deleterious None None None None I
T/E 0.3149 likely_benign 0.3025 benign -0.267 Destabilizing 0.999 D 0.756 deleterious None None None None I
T/F 0.4709 ambiguous 0.4678 ambiguous -0.927 Destabilizing 1.0 D 0.839 deleterious None None None None I
T/G 0.234 likely_benign 0.2165 benign -0.254 Destabilizing 0.997 D 0.699 prob.neutral None None None None I
T/H 0.3619 ambiguous 0.3535 ambiguous -0.439 Destabilizing 1.0 D 0.822 deleterious None None None None I
T/I 0.3227 likely_benign 0.3061 benign -0.293 Destabilizing 0.999 D 0.808 deleterious N 0.497756813 None None I
T/K 0.2065 likely_benign 0.2136 benign -0.373 Destabilizing 0.999 D 0.767 deleterious N 0.436807142 None None I
T/L 0.1684 likely_benign 0.1585 benign -0.293 Destabilizing 0.998 D 0.683 prob.neutral None None None None I
T/M 0.1514 likely_benign 0.1422 benign -0.258 Destabilizing 1.0 D 0.795 deleterious None None None None I
T/N 0.1318 likely_benign 0.1231 benign -0.199 Destabilizing 0.999 D 0.708 prob.delet. None None None None I
T/P 0.1364 likely_benign 0.1323 benign -0.254 Destabilizing 1.0 D 0.81 deleterious N 0.508707312 None None I
T/Q 0.2457 likely_benign 0.2426 benign -0.388 Destabilizing 1.0 D 0.812 deleterious None None None None I
T/R 0.1987 likely_benign 0.2132 benign -0.143 Destabilizing 0.999 D 0.809 deleterious N 0.487734607 None None I
T/S 0.1151 likely_benign 0.1075 benign -0.336 Destabilizing 0.905 D 0.379 neutral N 0.474613381 None None I
T/V 0.2206 likely_benign 0.2041 benign -0.254 Destabilizing 0.998 D 0.615 neutral None None None None I
T/W 0.7633 likely_pathogenic 0.79 pathogenic -1.027 Destabilizing 1.0 D 0.821 deleterious None None None None I
T/Y 0.4648 ambiguous 0.4723 ambiguous -0.718 Destabilizing 1.0 D 0.835 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.